✦ LIBER ✦

605 A Phase 1, Open-label, Dose-escalation Study of Oral Administration of the Investigational Agent MLN0128 in Combination with Paclitaxel (P) in Patients (pts) with Advanced Solid Malignancies

✍ Scribed by Burris, H.; Hart, L.; Kurkjian, C.; Berk, G.; Lipman, P.; Patel, C.; Rommel, C.; Martin, M.; Infante, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I, open-label, dose-escalation s

✍ Michael S. Gordon,David S. Mendelson,Mitchell Gross… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 200 KB

1209 POSTER ONX 0912, a Novel Oral Prote

✍ K. Papadopoulos; D. Mendelson; A.W. Tolcher; H.A. Burris; M. Gordon; H. Wong; D. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

365 A Phase 1b Open-label, Dose-escalati

✍ Lolkema, M.; Leong, S.; Voest, E.; Freas, E.; Shankar, G.; Brachmann, R.K.; Moss 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Phase Ia/II, two-arm, open-label, dose-e

✍ DeAngelo, D J; Spencer, A; Bhalla, K N; Prince, H M; Fischer, T; Kindler, T; Gil 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 593 KB

Phase 1, open-label, dose-escalation, an

✍ Bendell, Johanna C.; Hong, David S.; Burris, Howard A.; Naing, Aung; Jones, Suza 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 189 KB

A Phase I, open-label, dose escalation s

✍ John Marshall,Jimmy Hwang,Ferry A. L. M. Eskens… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 223 KB